<p>Diffusion’s Chief Medical Officer Dr. Chris Galloway provides an overview of the ILD-DLCO Trial, the third in a trio of Oxygenation Trials that will inform late-phase programs and clinical indications for lead drug candidate TSC.</p>

Fueling Life is a podcast brought to you by — and all about — Diffusion Pharmaceuticals, an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen where it is needed most. This podcast will explore the science and ongoing studies of trans sodium crocetinate (TSC), our first-in-class, small molecule therapeutic that enhances the diffusion of oxygen to hypoxic tissues.